Edition:
United Kingdom

Organovo Holdings Inc (ONVO.OQ)

ONVO.OQ on NASDAQ Stock Exchange Global Market

1.28USD
20 Jul 2018
Change (% chg)

$-0.04 (-3.03%)
Prev Close
$1.32
Open
$1.31
Day's High
$1.33
Day's Low
$1.26
Volume
201,703
Avg. Vol
200,349
52-wk High
$2.42
52-wk Low
$0.91

Latest Key Developments (Source: Significant Developments)

Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement
Monday, 26 Mar 2018 

March 26 (Reuters) - Organovo Holdings Inc ::ORGANOVO DIVISION SAMSARA SCIENCES ANNOUNCES MULTI-YEAR SUPPLY AGREEMENT WITH LONZA BIOSCIENCE SOLUTIONS.ORGANOVO HOLDINGS INC - ‍LONZA WILL MARKET HUMAN CELL PRODUCTS FROM SAMSARA FOR FURTHER DISTRIBUTION TO ITS CUSTOMERS​.ORGANOVO HOLDINGS INC - CO'S ‍UNIT, SAMSARA SCIENCES ENTERED NON-EXCLUSIVE SUPPLY AGREEMENT WITH LONZA BIOSCIENCE SOLUTIONS​.  Full Article

Organovo posts Q3 loss per share $0.09
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Organovo Holdings Inc :Organovo announces fiscal second-quarter 2018 results; company shifts commercial focus to higher-value disease modeling opportunities and updates full-year fiscal 2018 outlook.Q2 loss per share $0.09.Q2 revenue $1.4 million versus I/B/E/S view $1.4 million.Sees FY 2018 revenue $4.5 million to $6.5 million.Q2 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.  Full Article

Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Organovo Holdings Inc ::Organovo and Viscient Biosciences collaborate to develop custom research platform for studying liver disease.Says Viscient is targeting early discovery work for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis​.  Full Article

Organovo signs exclusive distributor agreement with Japanese Cosmo Bio
Wednesday, 14 Dec 2016 

Organovo Holdings Inc - : Announced an exclusive distributor agreement with Cosmo Bio Co Ltd for its novoview preclinical services in Japan . Company will work with cosmobio's drug discovery services team for access to customers, support projects in Japanese biopharmaceutical industry .Press release - Organovo signs exclusive distributor agreement with Cosmo Bio (Japan).  Full Article

Organovo Q1 loss per share $0.09
Thursday, 4 Aug 2016 

Organovo Announces Fiscal First : Quarter 2017 results; company affirms full-year fiscal 2017 and long-range outlook . Q1 revenue $900,000 . Q1 loss per share $0.09 .Affirmed fy 2017 outlook for total revenue, net cash utilization, initiation of commercial contracting for kidney tissue product.  Full Article

BRIEF-Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement

* ORGANOVO DIVISION SAMSARA SCIENCES ANNOUNCES MULTI-YEAR SUPPLY AGREEMENT WITH LONZA BIOSCIENCE SOLUTIONS